Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

被引:21
|
作者
Purdue, M. P. [1 ,2 ]
Lan, Q. [1 ]
Kemp, T. J. [3 ]
Hildesheim, A. [1 ]
Weinstein, S. J. [1 ]
Hofmann, J. N. [1 ]
Virtamo, J. [4 ]
Albanes, D. [1 ]
Pinto, L. A. [3 ]
Rothman, N. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Leidos Biomed Inc, HPV Immunol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA
[4] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland
关键词
B-CELL ACTIVATION; SOLUBLE CD30; MARKERS; IMMUNE; CD23; CYTOKINES;
D O I
10.1038/leu.2015.2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1429 / 1431
页数:3
相关论文
共 14 条
  • [1] Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma
    M P Purdue
    Q Lan
    T J Kemp
    A Hildesheim
    S J Weinstein
    J N Hofmann
    J Virtamo
    D Albanes
    L A Pinto
    N Rothman
    Leukemia, 2015, 29 : 1429 - 1431
  • [2] Serum sCD23 and sCD30 associated with non-Hodgkin lymphoma risk as far as 15 to 23 years after blood collection
    Purdue, Mark P.
    Lan, Qing
    Kemp, Troy J.
    Hildesheim, Allan
    Weinstein, Stephanie J.
    Albanes, Demetrius
    Pinto, Ligia A.
    Rothman, Nathaniel
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes
    Purdue, Mark P.
    Lan, Qing
    Langseth, Hilde
    Grimsrud, Tom K.
    Hildesheim, Allan
    Rothman, Nathaniel
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (12) : 3312 - 3319
  • [4] Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk
    Purdue, Mark P.
    Lan, Qing
    Hoffman-Bolton, Judith
    Hildesheim, Allan
    Callahan, Catherine L.
    Strickland, Paul
    Visvanathan, Kala
    Rothman, Nathaniel
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1780 - 1785
  • [5] Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis
    Levin, Lynn I.
    Breen, Elizabeth C.
    Birmann, Brenda M.
    Batista, Julie L.
    Magpantay, Larry I.
    Li, Yuanzhang
    Ambinder, Richard F.
    Mueller, Nancy E.
    Martinez-Maza, Otoniel
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (07) : 1114 - 1123
  • [6] Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue
    Schroeder, JR
    Saah, AJ
    Ambinder, RF
    Martinez-Maza, O
    Breen, EC
    Variakojis, D
    Margolick, JB
    Jacobson, LP
    Rowe, DT
    Hoover, DR
    CLINICAL IMMUNOLOGY, 1999, 93 (03) : 239 - 244
  • [7] ELEVATED SERUM LEVELS OF SOLUBLE CD23 (SCD23) PRECEDE THE APPEARANCE OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED NON-HODGKINS-LYMPHOMA
    YAWETZ, S
    CUMBERLAND, WG
    VANDERMEYDEN, M
    MARTINEZMAZA, O
    BLOOD, 1995, 85 (07) : 1843 - 1849
  • [8] Circulating sCD27 and sCD30 in samples collected fifteen years apart and non-Hodgkin lymphoma risk: Findings from the CLUE-I and CLUE-II cohorts
    Purdue, Mark P.
    Lan, Qing
    Hoffman-Bolton, Judith
    Hildesheim, Allan
    Strickland, Paul
    Visvanathan, Kala
    Rothman, Nathaniel
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Differential-diagnostic and prognostic value of serum cytokines sCD30, sIL2R, IL-10 and IL-6 in Hodgkin's disease and non-Hodgkin's lymphomas
    Yaguzhinskaya, OE
    Lazarev, IE
    Nikitin, EA
    Loginova, IV
    Samoilova, RS
    Gemdzhan, EG
    Novikov, VA
    Mamilyaeva, ZK
    Pivnik, AV
    TERAPEVTICHESKII ARKHIV, 2001, 73 (04) : 45 - 51
  • [10] Dynamics of Soluble B-Cell Activation Markers sCD27 and sCD30 and Risk of B-Cell Lymphoma: A Prospective Study Using Repeated Plasma Samples Donated up to 25 Years Pre-Diagnosis
    Spath, Florentin
    Wibom, Carl
    Krop, Esmeralda J. M.
    Johansson, Ann-Sofie
    Bergdahl, Ingvar
    Vermeulen, Roel
    Melin, Beatrice
    BLOOD, 2016, 128 (22)